GovChime
Notice ID: 0aa57e1e131f4bb094422890c1d769f8Special Notice

Isolator Unit - Outbreak

Archived on August 5, 2022. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
1:00 PM UTC−04:00
Posted
July 21, 2022
Notice type
Special Notice
Set-aside
Total Small Business Set-Aside (FAR 19.5)
NAICS
334516: Analytical Laboratory Instrument Manufacturing
Agency
Department of Health and Human ServicesCENTERS FOR DISEASE CONTROL AND PREVENTION

Notice details

Office
CENTERS FOR DISEASE CONTROL AND PREVENTION
Last updated
Dec 4, 2025

Identifiers

Solicitation number
75D301-22-Q-75258
Notice ID
0aa57e1e131f4bb094422890c1d769f8

Description

The Centers for Disease Control and Prevention intends to award a sole source firm fixed price purchase order to BioQuell Inc. of Horsham, PA 19044 for Bioquell Qube M-2. (See RFQ attached.) The Bioquell Qube is a modular and mobile sterile environment that can function as a closed sterile testing environment required for USP <71>. To the best of our knowledge all other sterility testing isolators were in-place that required a permanent space and access to building ducts. This is a plug and play modular system that is on wheels to be stored anywhere while not in use. Other products considered had footprint that were too large and required permanent/dedicated space to be used. The Qube modularity and built-in environmental control and auditing features are key to a USP sterility testing requirement. These same requirements will be a factor in our joint FDA/CDC product implicated HAI outbreak investigations and give us the same audit and compliance abilities required by FDA regulated manufacturers. Therefore, it is in the Government best interest to continue using Bioquell Qube products. This contract action is for supplies or services for which the Government intends to solicit and negotiate with only one source under the authority of FAR 13.106-1(b) (SAP) and 41 U.S.C. 3304(a)(1). Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive quotations; however, all quotations/responses received within fifteen (15) days of the issuance of this notice will be considered by the government. A determination by the government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. Any quotation/response should be emailed to contract specialist at boh9@cdc.gov by COB July 26, 2022.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:75D301-22-Q-75258
  1. Special NoticeCurrentJul 21, 2022

    Isolator Unit - Outbreak

    Notice 0aa57e1e131f4bb094422890c1d769f8 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75D301-22-Q-75258

Archive Date

Aug 5, 2022

Office Address

Atlanta, GA, 30333, US